COX-2: Where are we in 2003? - Distinction from NSAIDs becoming blurred
The distinction between cyclooxygenase-2-selective inhibitors (CSIs) and nonsteroidal anti-inflammatory drugs ultimately must be clinical and must be clinically and economically relevant. This distinction needs to be demonstrated in a substantial and clinically relevant difference in the respective...
保存先:
| 出版年: | Arthritis Res Ther |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2003
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC165043/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12723976/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/ar747 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|